Nanomedicine for increasing the oral bioavailability of cancer treatments

58Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract: Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent decades, the fields of material science and nanomedicine have generated several delivery platforms with high potential for overcoming multiple barriers associated to oral administration. This review describes the properties of several nanodelivery systems that improve the bioavailability of orally administered therapeutics, highlighting their advantages and disadvantages in generating successful anticancer oral nanomedicines. Graphical Abstract: [Figure not available: see fulltext.].

Cite

CITATION STYLE

APA

Parodi, A., Buzaeva, P., Nigovora, D., Baldin, A., Kostyushev, D., Chulanov, V., … Zamyatnin, A. A. (2021, December 1). Nanomedicine for increasing the oral bioavailability of cancer treatments. Journal of Nanobiotechnology. BioMed Central Ltd. https://doi.org/10.1186/s12951-021-01100-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free